Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia
- 23 August 2011
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 156 (3), 276-280
- https://doi.org/10.1016/j.jconrel.2011.08.019
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IXJournal of Controlled Release, 2011
- Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and OptimizationChemical Reviews, 2010
- Contrast-Enhanced MRI-Guided Photodynamic Cancer Therapy with a Pegylated Bifunctional Polymer ConjugatePharmaceutical Research, 2008
- β-Lapachone-containing PEG–PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cellsJournal of Controlled Release, 2007
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Porphyrin-fullerene C60 Dyads with High Ability to Form Photoinduced Charge-separated State as Novel Sensitizers for Photodynamic Therapy¶Photochemistry and Photobiology, 2005
- Influence of Conformation on the EPR Spectrum of 5,5-Dimethyl-1-hydroperoxy-1-pyrrolidinyloxyl: A Spin Trapped Adduct of SuperoxideThe Journal of Organic Chemistry, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Singlet oxygen quantum yields from halogenated chlorins: potential new photodynamic therapy agentsJournal of Photochemistry and Photobiology A: Chemistry, 2000
- MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapyEuropean Journal Of Cancer, 1992